All Cancer News

Add-Aspirin is now open at 11 centres in India:

  • Tata Memorial Hospital, Mumbai
  • Chennai Breast Centre
  • Jehangir Clinical Development Centre, Pune
  • Tata Medical Centre, Kolkata
  • Meditrina Institute of Medical Sciences, Nashik
  • Shatabdi Hospital, Nagpur
  • Vikram & Fortis Hospital, Bengaluru
  • Cancer Institute (WIA), Chennai
  • Regional Cancer Centre, Trivandrum
  • Meenakshi Mission Hospital, Madurai
  • IndoAmerican Cancer Centre, Hyderabad

New study reports: “No benefit of Celecoxib in Breast Cancer Patients”A recent study looking at the use of the non-steroidal anti-inflammatory drug (NSAID), celecoxib, in participants who have had sur ...

A recent report has provided further evidence to suggest that individuals who take aspirin following a diagnosis of colorectal (bowel) cancer are less likely to die from their cancer. The study included 2400 individuals with bowel cancer from Australia, Canada and the U.S... 

A new piece of research has provided further evidence to suggest that individuals who take aspirin have a lower risk of developing breast cancer. Researchers collected information from 57,000 female teachers in California over a period of more than 15 years. ...

Further research has provided more evidence to suggest that individuals who take aspirin have a lower risk of dying from cancer. Researchers looked at data from two very large studies that followed groups of nurses and other healthcare professionals (more than 130,000 people in total) over a period of up to 32 years...